|
V4505
|
JNJ-54175446 |
1627902-21-9 |
JNJ-54175446 (JNJ54175446) is a novel, potent and selective brain penetrantP2X7 receptorantagonist being developed for treating major depressive disorder. |
|
V4514
|
JNJ-61432059 |
2035814-50-5 |
JNJ-61432059 is a novel, potent, oral bioactive and selective negative modulator ofAMPAR (α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors)associated with trans-membrane AMPAR regulatory protein (TARP) γ-8, with apIC50of 9.7 for GluA1/γ-8. |
|
V4512
|
JNJ4796 |
2241664-16-2 |
JNJ4796 is a novel, potent and oral bioactive fusion inhibitor of influenza virus, which neutralizes influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion. |
|
V4789
|
K-Ras G12C-IN-1 |
1629265-17-3 |
K-Ras G12C-IN-1 is a novel, potent and irreversible/covalent inhibitor of K-Ras protein with G12C mutation. |
|
V4788
|
K-Ras G12C-IN-2 |
1629267-75-9 |
K-Ras G12C-IN-2 is a novel, potent and irreversible/covalent inhibitor of K-Rasprotein with G12C mutation. |
|
V4790
|
K-Ras G12C-IN-3 |
1629268-19-4 |
K-Ras G12C-IN-3 is a novel, potent and irreversible/covalent inhibitor of K-Rasprotein with G12C mutation. |
|
V4838
|
KKI 5 |
97145-43-2 |
KKI 5 is, a synthetic peptide, is a novel and potent serine protease inhibitor that inhibits kallikrein and plasmin. |
|
V4784
|
KRas G12C inhibitor 1 |
2158297-28-8 |
KRAS G12C inhibitor 1 is a novel and potent inhibitor of KRAS. |
|
V4785
|
KRas G12C inhibitor 2 |
2206735-61-5 |
KRAS G12C inhibitor 2 is a novel and potent inhibitor of KRAS. |
|
V4786
|
KRas G12C inhibitor 3 |
2206735-75-1 |
KRAS G12C inhibitor 3 is a novel and potent inhibitor of KRAS. |
|
V4783
|
KRas G12C inhibitor 4 |
2206736-07-2 |
KRas G12C inhibitor 4 is a novel and potent inhibitor of KRAS. |
|
V4787
|
KRas G12C inhibitor 5 |
2158297-63-1 |
KRAS G12C inhibitor 5 is a novel and potent inhibitor of KRAS. |
|
V4801
|
KX-01-191 |
2211903-84-1 |
KX-01-191 (compound 5c′) is a tin reagent precursor. |
|
V5159
|
L 601920-0 (Methyl-3β-hydroxycholenate) |
20231-57-6 |
Methyl-3β-hydroxycholenate is a ROR gamma modulator. |
|
V4973
|
Lanosterol |
79-63-0 |
Lanosterol, a naturally-occurring triterpenoid derivative, is a key imtermediate in the biosynthesis of Cholesterol. |
|
V5128
|
Lck inhibitor II |
918870-43-6 |
Lck inhibitor II is a novel, potent, cell-permeable, ATP competitive amd tri-substituted pyrimidine that acts as a highly potent Lck (lymphocyte specific kinase) inhibitor with the potential for cancer treatment. |
|
V4664
|
LEQ-506 |
1057677-92-5 |
LEQ-506 (also known as NVP-LEQ506) is a novel, orally bioavailable and second-generation small-molecule inhibitor ofsmoothened(Smo) withIC50s of 2 and 4 nM in human and mouse, respectively. |
|
V4868
|
Lometrexol disodium |
120408-07-3 |
Lometrexol is a novel and potent antimetabolite that belongs to the folate class with antineoplastic activity. |
|
V4844
|
LY 178002 |
107889-32-7 |
LY 178002 is a novel and potent inhibitor of5-lipoxygenase,phospholipase A2withIC50of 0.6 μM for 5-1ipoxygenase, it inhibits cellular production of LTB4 by human polymorphonuclear leukocytes, and shows relatively weak inhibition oncyclooxygenase. |
|
V4842
|
LY 222306 |
154446-98-7 |
LY 222306 is an inhibitor (blocker/antagonist) of glycinamide ribonucleotide formyltransferase ((GARFT)) with Ki of 0.77 nM. |